Download PDF
Thromb Haemost 2005; 94(04): 879-880
DOI: 10.1055/s-0037-1615580
Case Report
Schattauer GmbH

Acquired Glanzmann´s thrombasthenia variant and immune thrombocytopenia in a renal transplant recipient receiving tacrolimus

Christian Morath
1   Department of Nephrology, University of Heidelberg, Heidelberg, Germany
,
Till Hoffmann
2   Department of Hemostasis and Transfusion Medicine, University of Düsseldorf, Düsseldorf, Germany
,
Elisabeth M. Kirchhoff
2   Department of Hemostasis and Transfusion Medicine, University of Düsseldorf, Düsseldorf, Germany
,
Jeanne Sis
1   Department of Nephrology, University of Heidelberg, Heidelberg, Germany
,
Martin Zeier
1   Department of Nephrology, University of Heidelberg, Heidelberg, Germany
,
Rüdiger E. Scharf
2   Department of Hemostasis and Transfusion Medicine, University of Düsseldorf, Düsseldorf, Germany
,
Konrad Andrassy
1   Department of Nephrology, University of Heidelberg, Heidelberg, Germany
› Author Affiliations
Further Information

Publication History

Received20 December 2004

Accepted after revision09 July 2005

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Malik U, Dutcher JP, Oleksowicz L. Acquired Glanzmann’s thrombasthenia associated with Hodgkin’s lymphoma: a case report and review of the literature. Cancer 1998; 82: 1764-8.
    CrossrefPubMedGoogle Scholar
  • 2 Christie DJ, Sauro SC, Cavanaugh AL. et al. Severe thrombocytopenia in an acquired immunodeficiency syndrome patient associated with pentamidine-dependent antibodies specific for glycoprotein IIb/IIIa. Blood 1993; 82: 3075-80.
    CrossrefPubMedGoogle Scholar
  • 3 Gottschall JL, Elliot W, Lianos E. et al. Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity. Blood 1991; 77: 306-10.
    CrossrefPubMedGoogle Scholar
  • 4 Bettaieb A, Fromont P, Louache F. et al. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIVrelated immune thrombocytopenic purpura. Blood 1992; 80: 162-9.
    CrossrefPubMedGoogle Scholar
  • 5 Scharf RE, Tomer A, Marzec UM. et al. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992; 12: 1475-87.
    CrossrefPubMedGoogle Scholar
  • 6 Scharf RE. Molecular basis and clinical aspects of hereditary megakaryocyte and platelet membrane glycoprotein disorders. Hämostaseologie 1996; 16: 114-38.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Shinohara K, Okafuji K, Ayame H. et al. Aplastic anemia caused by allopurinol in renal insufficiency. Am J Hematol 1990; 35: 68.
    CrossrefPubMedGoogle Scholar
  • 8 Lin YW, Okazaki S, Hamahata K. et al. Acute pure red cell aplasia associated with allopurinol therapy. Am J Hematol 1999; 61: 209-11.
    CrossrefPubMedGoogle Scholar
  • 9 Rawal A, Sarode R, Curtis BR. et al. Acquired Glanzmann’s thrombasthenia as part of multiple-autoantibody syndrome in a pediatric heart transplant patient. J Pediatr 2004; 144: 672-4.
    CrossrefPubMedGoogle Scholar
  • 10 Prieto J, Yuste JR, Beloqui O. et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23: 199-204.
    CrossrefPubMedGoogle Scholar
  • 11 Granel B, Swiader L, Veit V. et al. [Pseudo-Glanzmann thrombasthenia in the course of autoimmune thrombocytopenic purpura]. Rev Med Interne 1998; 19: 823-5.
    CrossrefPubMedGoogle Scholar